Title
Acute Rheumatic Fever Status Does Not Affect Severity of Rheumatic Heart Disease at Diagnosis
Conference Name
Cardiac Society of Australia and New Zealand 4th Indigenous Cardiovascular Health Conference
Conference Start Date
2025-06-17
Conference End Date
2025-06-19
Conference Location
Sydney, Gadigal, Australia
Author(s)
Abstract
Aim
Acute rheumatic fever (ARF) is a precursor to rheumatic heart disease (RHD). Many cases of RHD are detected in the absence of ARF history. It is not currently known if ARF at diagnosis influences RHD severity or progression. Our aim was to investigate the link between ARF diagnosis and RHD severity.
Method
The sample included young individuals (5–20 years) from the Northern Territory of Australia with RHD diagnosed between 2012–2021. Echocardiograms were independently reviewed and RHD stage determined using the 2023 World Heart Federation RHD diagnostic guidelines. Findings were compared to the original diagnostic report and where there was discordance, a third observer independently reviewed the images. RHD status at follow-up was compared between individuals with ARF diagnosis and those without.
Results
292 individuals were included: mean age was 11.9 years (SD=3.8 years) and 55.1% were female. 192 (65.8%) were with ARF at the time of RHD diagnosis and 100 (34.2%) without.
There was no difference in the proportions of early RHD (Stage A or Stage B) and advanced RHD (Stage C or D) at baseline (p=0.440) between the groups.
Follow-up data was available for 230 individuals and those with ARF were more likely to change in severity (66.7%) compared to those with no ARF (41.9%, p=0.003, see Figure).
Conclusion
Advanced RHD proportions were similar between those with and those without ARF at diagnosis. Importantly, progression to advanced disease was seen in both groups. A lack of ARF diagnosis should not preclude diagnosis of RHD in individuals from high-risk populations.
Acute rheumatic fever (ARF) is a precursor to rheumatic heart disease (RHD). Many cases of RHD are detected in the absence of ARF history. It is not currently known if ARF at diagnosis influences RHD severity or progression. Our aim was to investigate the link between ARF diagnosis and RHD severity.
Method
The sample included young individuals (5–20 years) from the Northern Territory of Australia with RHD diagnosed between 2012–2021. Echocardiograms were independently reviewed and RHD stage determined using the 2023 World Heart Federation RHD diagnostic guidelines. Findings were compared to the original diagnostic report and where there was discordance, a third observer independently reviewed the images. RHD status at follow-up was compared between individuals with ARF diagnosis and those without.
Results
292 individuals were included: mean age was 11.9 years (SD=3.8 years) and 55.1% were female. 192 (65.8%) were with ARF at the time of RHD diagnosis and 100 (34.2%) without.
There was no difference in the proportions of early RHD (Stage A or Stage B) and advanced RHD (Stage C or D) at baseline (p=0.440) between the groups.
Follow-up data was available for 230 individuals and those with ARF were more likely to change in severity (66.7%) compared to those with no ARF (41.9%, p=0.003, see Figure).
Conclusion
Advanced RHD proportions were similar between those with and those without ARF at diagnosis. Importantly, progression to advanced disease was seen in both groups. A lack of ARF diagnosis should not preclude diagnosis of RHD in individuals from high-risk populations.
Publication information
Acute Rheumatic Fever Status Does Not Affect Severity of Rheumatic Heart Disease at Diagnosis Williamson, J. et al. Heart, Lung and Circulation, Volume 34, S89 - S90
Date Issued
2025-06-17
ISSN
1443-9506
Type
Conference abstract
Journal Title
Heart, lung & circulation
VIEW WEB RESOURCE
Permanent link to this record
Owning collection
